Litcius/Paper detail

Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma

Kevin Bi, Meng Xiao He, Ziad Bakouny, Abhay Kanodia, Sara Napolitano, Jingyi Wu, Grace Grimaldi, David A. Braun, Michael S. Cuoco, Angie Mayorga, Laura DelloStritto, Gabrielle Bouchard, John A. Steinharter, Alok K. Tewari, Natalie I. Vokes, Erin Shannon, Maxine Sun, Jihye Park, Steven L. Chang, Bradley A. McGregor, Rizwan Haq, Thomas Denize, Sabina Signoretti, Jennifer L. Guerriero, Sébastien Vigneau, Orit Rozenblatt–Rosen, Asaf Rotem, Aviv Regev, Toni K. Choueiri, Eliezer M. Van Allen

2021Cancer Cell628 citationsDOIOpen Access PDF

Topics & Concepts

Immune checkpointImmune systemCancer researchImmunotherapyTumor microenvironmentDownregulation and upregulationCytotoxic T cellRenal cell carcinomaBiologyCancer immunotherapyReprogrammingCancerCancer cellEffectorT cellCellImmunologyMedicineOncologyGeneGeneticsBiochemistryIn vitroCancer Immunotherapy and BiomarkersRenal cell carcinoma treatmentFerroptosis and cancer prognosis
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma | Litcius